Literature DB >> 11907487

Shed human enterocytes as a tool for the study of expression and function of intestinal drug-metabolizing enzymes and transporters.

Hartmut Glaeser1, Siegfried Drescher, Heiko van der Kuip, Christoph Behrens, Anke Geick, Oliver Burk, John Dent, Andrew Somogyi, Oliver Von Richter, Ernst-Ulrich Griese, Michel Eichelbaum, Martin F Fromm.   

Abstract

OBJECTIVES: Intestinal metabolism and transport are now recognized as protective barriers against orally ingested xenobiotics, including drugs. However, in vitro studies of the expression and function of intestinal proteins are hampered by the limited availability of human intestinal tissues. Because enterocytes are constantly shed in large numbers into the gut lumen, this study investigated whether these cells could be collected with a multilumen perfusion catheter and whether they are functionally active.
METHODS: In healthy volunteers, a 20-cm isolated jejunal segment was generated with the perfusion catheter by inflating 2 balloons with air. Shed cells were characterized by fluorescence-activated cell sorting analysis for leukocyte-specific CD45 and enterocyte-specific villin, as well as for apoptosis. Homogenates of the cells were used for reverse transcriptase polymerase chain reaction and Western blotting. Cytochrome P450 enzyme activity was determined with the calcium channel blocker verapamil as a substrate.
RESULTS: On average, 4.83 mg protein and 56.23 million cells were collected from a 20-cm segment during 2 hours. A total of 84.2% of the cells were positive for enterocyte-specific villin, and only 1.6% of the collected cells were positive for CD45. The majority of cells (65.3%) were not in early or late apoptosis or necrosis. In all volunteers, drug-metabolizing enzymes (such as members of the cytochrome P450 family) could be detected as both messenger ribonucleic acid and proteins. Consistent with expression data, formation of verapamil metabolites catalyzed by CYP3A4 and CYP2C was shown.
CONCLUSIONS: The majority of shed human enterocytes collected with a multilumen perfusion catheter were still functionally active and not apoptotic. Harvesting of spontaneously shed enterocytes provides a new tool for studies on expression and function of intestinal proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907487     DOI: 10.1067/mcp.2002.121370

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  9 in total

1.  Phase I and II metabolism and MRP2-mediated export of bosentan in a MDCKII-OATP1B1-CYP3A4-UGT1A1-MRP2 quadruple-transfected cell line.

Authors:  C Fahrmayr; J König; D Auge; M Mieth; K Münch; J Segrestaa; T Pfeifer; A Treiber; Mf Fromm
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

2.  Influence of rifampicin on the expression and function of human intestinal cytochrome P450 enzymes.

Authors:  H Glaeser; S Drescher; M Eichelbaum; M F Fromm
Journal:  Br J Clin Pharmacol       Date:  2005-02       Impact factor: 4.335

Review 3.  Cytochrome P450 and xenobiotic receptor humanized mice.

Authors:  Frank J Gonzalez; Ai-Ming Yu
Journal:  Annu Rev Pharmacol Toxicol       Date:  2006       Impact factor: 13.820

Review 4.  Pharmacokinetic interactions with rifampicin : clinical relevance.

Authors:  Mikko Niemi; Janne T Backman; Martin F Fromm; Pertti J Neuvonen; Kari T Kivistö
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

5.  P-glycoprotein increases from proximal to distal regions of human small intestine.

Authors:  Stéphane Mouly; Mary F Paine
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

6.  Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide.

Authors:  Tanja Busk Bidstrup; Nicolaj Stilling; Per Damkier; Birgitte Scharling; Mikael Søndergård Thomsen; Kim Brøsen
Journal:  Eur J Clin Pharmacol       Date:  2004-03-19       Impact factor: 2.953

7.  Relevance of conserved lysine and arginine residues in transmembrane helices for the transport activity of organic anion transporting polypeptide 1B3.

Authors:  H Glaeser; K Mandery; H Sticht; M F Fromm; J König
Journal:  Br J Pharmacol       Date:  2010-01-22       Impact factor: 8.739

Review 8.  Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions.

Authors:  Jean-Marie Nicolas; François Bouzom; Chanteux Hugues; Anna-Lena Ungell
Journal:  Biopharm Drug Dispos       Date:  2017-02-06       Impact factor: 1.627

Review 9.  The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug-Drug Interactions.

Authors:  K Sandy Pang; H Benson Peng; Keumhan Noh
Journal:  Pharmaceutics       Date:  2020-04-01       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.